Skip to content

Ayurvedic treatment of severe Dry eye disease

Cell repairing effect of topical application of Durvagritha in severe Dry Eye Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035741
Enrollment
16
Registered
2021-08-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

Intervention1: Durvagritha: The drug will be used as eye drops at a dose of 5 drops at bed time for a period of 45 days Control Intervention1: Not applicable: Not applicalbe

Sponsors

Muhammed Nissam C P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: �Fresh and Diagnosed cases of Dry eye Syndrome. �Patients who are willing and competent to give consent are included in the study

Exclusion criteria

Exclusion criteria: 1 Subjects who had undergone ophthalmic surgeries like cataract, glaucoma, pterygium etc. 2 External ocular diseases like conjunctivitis, corneal ulcer, episcleritis, and scleritis 3 History of use of drugs like steroids until a month prior to the study. 4 Subjects who are under Ayurvedic treatment for Dry eye. 5 Subjects who underwent any type of snehana therapy. 6 Patients who are not eligible to use Durvagritha.

Design outcomes

Primary

MeasureTime frame
Conjuctival impression cytology reportTimepoint: 0th day, 14th day , 28th day and 45th day

Secondary

MeasureTime frame
OSDI Score Schirmer�s test TBUT Timepoint: 0th day, 14th day , 28th day and 45th day

Countries

India

Contacts

Public ContactMuhammed Nissam C P

Govt Ayurveda College, Thripunithura

doctorsreejamd@gmail.com7034115701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026